16Jun
Read more...
18Apr
Precision Biologics to Present Combination Immunotherapy of a Novel NEO-Epitope Antibody Targeting Ovarian and Uterine Cancer at the AACR Annual Meeting 2016
New Orleans. LA– April 17, 2016 — Precision Biologics, a clinical stage biotechnology company...
18Mar
NCI Investigators Collaborate with Moonshoot 2020
https://twitter.com/nciresearchctr/status/694520668679962624
21Jan
Precision Biologics Reaches First Clinical Trial Milestone: Immunotherapy Trial Demonstrates Encouraging Survival Rates in Patients with Metastatic Colorectal Cancer Who Failed all Standard Therapy
Over 30% of patients who failed all standard chemo and antibody therapy remain alive after...
21Dec
Precision Biologics, Announces Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI)
December 21, 2015 08:00 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)-- Today Precision Biologics Inc,...
20Aug
Beth Israel Deaconess Medical Center (BIDMC) Joins Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial
Precision Biologics is pleased to announce the addition of Beth Israel Deaconess (BIDMC)as a collaborator...
18Jun
Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts General Hospital (MGH) Join Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial
Precision Biologics is pleased to announce the addition of Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts...
02Jun
Dr. Philip Arlen to Speak at 16th Annual Drug Discovery Summit
Dr. Philip Arlen will be speaking at this years Drug Discovery Summit June 8-9th in...
20May
Precision Biologics Completes Patient Accrual to its Ensituximab Phase 2 Colorectal Cancer Study
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
18May
Yale Cancer Center and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Joins Precision Biologics as Collaborators
Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...